Pathological Upstaging During Radical Cystectomy Is Associated With Worse Recurrence-free Survival in Patients With Bacillus Calmette-Guerin-refractory Bladder Cancer

Urology

Volumn 74, Issue 6, 2009, Pages 1276-1280

  Guzzo, Thomas J ^a   Magheli, Ahmed ^a   Bivalacqua, Trinity J ^a   Nielsen, Matthew E ^a   Attenello, Frank J ^a   Schoenberg, Mark P ^a   Gonzalgo, Mark L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT FAILURE; URINARY BLADDER NEOPLASMS;

EID: 70749140223     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.092     Document Type: Article

References (20)

1. Nieder A.M., Brausi M., Lamm D., et al. Management of stage T1 tumors of the bladder: International consensus panel. Urology 66 (2005) 108-125
2. Brandau S., and Suttmann H. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed Pharmacother. 61 (2007) 299-305
3. Lambert E.H., Pierorazio P.M., Olsson C.A., et al. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int. 100 (2007) 33-36
4. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol. 151 (1994) 31-35
5. Freeman J.A., Esrig D., Stein J.P., et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76 (1995) 833-839
6. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder cancer. BJU Int. 95 (2005) 786-790
7. Cheng L., Neumann R.M., Weaver A.L., et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol. 113 (2000) 275-279
8. Dutta S.C., Smith Jr. J.A., Shappell S.B., et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 166 (2001) 490-493
9. Huguet J., Crego M., Sabate S., et al. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol. 48 (2005) 53-59
10. Gupta A., Lotan Y., Bastian P.J., et al. Outcomes of patients with clinical T1 grade 2 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 71 (2008) 302-307
11. Bianco Jr. F.J., Justa D., Grignon D.J., et al. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol. 22 (2004) 290-294
12. Parekh D.J., Bochner B.H., and Dalbagni G. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J Clin Oncol. 24 (2006) 5519-5527
13. Lamm D.L. Bacillus Calmette-Guerin immunotherapy for bladder cancer. J Urol. 134 (1985) 40-47
14. Krege S., Giani G., Meyer R., et al. A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. J Urol. 156 (1996) 962-966
15. Sylvester R.J., van der Meijden A.P., and Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized trials. J Urol. 168 (2002) 1964-1970
16. Shahin O., Thalmann G.N., Rentsch C., et al. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol. 169 (2003) 96-100
17. Herr H.W., and Sogani P.C. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol. 166 (2001) 1296-1299
18. Dalbagni G., Herr H.W., and Reuter V.E. Impact of second transurethral resection on the staging of T1 bladder cancer. Urology 60 (2002) 822-824
19. Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves initial response to bacillus Calmette-Guerin therapy. J Urol. 174 (2005) 2134-2137
20. Schrier B.P., Hollander M.P., van Rhijn B.W., et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol. 45 (2004) 292-296